Fundz

Blue Whale Bio reported raising $5 Million in an initial SEC Form D filing, from an offering of $15 Million

PRIVATEOct 16, 2025

Amount Raised

$5 Million

$5 Million sold, per SEC Form D (first sale Oct 10, 2025)

Round Type

Venture

PhiladelphiaBiotechnology

Who to call at BlueWhale Bio, and when

A new round usually means BlueWhale Bio is about to hire and buy. The teams that reach out first get the meeting.

  • An alert the day BlueWhale Bio raises, hires an executive or expands, scored against what you sell
  • The decision-makers there, with verified emails
  • Who you already know at BlueWhale Bio, from your own LinkedIn network

Works inside ChatGPT and Claude. Ask who to call at BlueWhale Bio. With Fundz connected, it knows.

Watch Fundz in
See plan options
Trusted byOracleSnowflakeCloudflareLinkedInGoogleSalesforce 4.8/5 on G2

Company Information

Company

BlueWhale Bio

Location

Philadelphia, Pennsylvania, United States

About

BlueWhale Bio is dedicated to accelerating the growth and adoption of cell-based therapies. With the demand for cell therapy products surpassing supply, BlueWhale Bio aims to address critical shortcomings in the current treatment paradigm. The company is developing a portfolio of groundbreaking products that bring the full benefits of cell therapy to more patients faster and at lower costs. For the Synecta™ platform, we focus on activation and expansion, as this early stage in the cell therapy manufacturing process defines which cells can be effectively processed and sets the stage for the efficiency and simplicity of all downstream steps.

AI made execution free. Knowing first is the whole game now.

Fundz sees it the moment BlueWhale Bio raises, hires an exec or expands, usually minutes after it happens, and tells you who to reach.

Related People

2 contacts
Predictive Intelligence
Strategic

ML-powered predictions for BlueWhale Bio's next move

See what Strategic adds

BlueWhale Bio raised. Fundz records a round at a median of 3.6 minutes from the SEC filing, with the decision-maker attached.

145 of these a day, filtered to the companies you pick, with the decision-maker attached.

5 screens from a live account. No signup.

Fundz is a real-time business intelligence platform powered by agentic AI that proactively delivers personalized daily signals, including funding rounds, executive changes, M&A activity, 13F institutional filings, SEC 8-K events, investor activity, and website modifications, based on each user's watchlist and ICP. A trusted data source at firms such as BlackRock, Oracle, Kleiner Perkins, LinkedIn, HubSpot, and Cloudflare, Fundz democratizes the institutional-grade intelligence that previously required a PitchBook or Bloomberg terminal. Features include FundzWatch™ for automated website change detection, Daily Briefing for AI-powered daily briefings, and unified cross-signal alerts across 281,000+ organizations. Developers and data teams can access these signals programmatically via the Fundz Funding Data API, with transparent published pricing.